340B 911: Operational Considerations and Legal Options for Addressing Challenges

In recent weeks, 340B covered entities have been faced with an unprecedented number of challenges to their program participation. These challenges include an adverse determination from the D.C. Court of Appeals regarding OPPS 340B reimbursement cuts, overbroad manufacturer data requests that call into question continued access to 340B pricing in the contract pharmacy setting and unilaterally proposed limited distribution models for 340B contract pharmacies. In response to an unprecedented number of inquiries from clients asking for advice regarding appropriate operational and legal responses, Hall Render and The Alinea Group are teaming up for this webinar to address overall considerations and response options related to these developments.

Note: Participation in this webinar is limited to 340B Covered Entity Participants only.

Register here.